After the United States authorities informed that as of next November only travelers who have a complete vaccination scheme against COVID-19 will be able to enter the United States, it was specified that people immunized with the Russian Sputnik V vaccine will not be able to enter the country.
The Washington Post newspaper revealed that the plan launched by the federal government “appears to exclude many people who consider themselves fully immunized, including millions who have received two doses of the Sputnik V vaccine from Russia .”
According to the newspaper, the prohibition of entering the United States for people vaccinated with Sputnik V, is a new blow to its manufacturers, who were already in trouble due to their low acceptance of immunization.
“More broadly, the US plan is another blow to the makers of Sputnik V, which Moscow has proudly proclaimed as the first registered coronavirus vaccine for use. Although the vaccine was destined to be a powerful tool of pandemic diplomacy, its limited acceptance abroad and slow delivery rates have left it behind, not only Western vaccines but also those manufactured by Chinese manufacturers, “says the Washington Post.
In the publication, they mention that this measure will not only affect thousands of Russians but also anyone who has received the two doses of Sputnik V, regardless of their nationality.
According to the Washington Post, approximately 300,000 Russians visited the United States in 2019, according to the American Travel Association.
The US Food and Drug Administration (FDA) mentioned that foreigners vaccinated with immunizations approved by them and by the World Health Organization (WHO) may enter US soil.
So far, neither the FDA nor the WHO has granted emergency use to Sputnik V.
Those who received a full schedule from Pfizer, Moderna or Janssen, which are FDA-approved vaccines, will be able to travel to the United States.
In addition to these three drugs, the WHO approved the emergency use of the AstraZeneca and the Chinese Sinopharm and Sinovac vaccines.